Skip to main content

RAD June 2021 Virtual Conference Abstracts & Posters

Abstracts have been published in the September 2021 issue of the British Journal of Dermatology and can be found here:

#516 - Efficacy of Abrocitinib Monotherapy for the Treatment of Moderate-to-Severe Atopic Dermatitis by Race

Andrew F. Alexis, Jonathan I. Silverberg, Zakiya P. Rice, April W. Armstrong, Seemal R. Desai, Luz Fonacier, Kenji Kabashima, Mark Levenberg, Pinaki Biswas, Ricardo Rojo Cella, Gary L. Chan

#519 - Abrocitinib in the Treatment of Moderate-to-Severe Atopic Dermatitis Refractory to Dupilumab Treatment: An Analysis of JADE-EXTEND, a Phase 3 Long-Term Extension Study

Vivian Shi, Tina Bhutani, Mette Deleuran, Luz Fonacier, Stephen Shumack, Fan Zhang, Michael C. Cameron, Gary Chan, Hernan Valdez, Natalie Yin

#520 - Depth and Rapidity of Response With Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in JADE COMPARE

Peter Lio, Mark Boguniewicz, Andrew Alexis, Mark Lebwohl, Kristian Reich, Andrew Pink, Kenji Kabashima, Robert Bissonnette, Roman J. Nowicki, Hernan Valdez, Fan Zhang, Marco DiBonaventura, Claire Clibborn, Michael C. Cameron

#521 - Interpreting the Relationship Between Pruritus and Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-1 and MONO-2

Melinda J. Gooderham, Gil Yosipovitch, Sonja Ständer, Luz Fonacier, Jacek C. Szepietowski, Mette Deleuran, Giampiero Girolomoni, Andrew G. Bushmakin, Joseph C. Cappelleri, Melissa Watkins, Claire Feeney, Hernan Valdez, Ricardo Rojo, Marco DiBonaventura, Daniela E. Myers

#522 - Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis: Stratified Analysis Across 3 Clinical Trials

Eric Simpson, Peter Lio, Candrice Heath, Mark Boguniewicz, Mark Levenberg, Pinaki Biswas, Saleem Farooqui, Urs Kerkmann

#523 - Long-Term Management of Moderate-to-Severe Atopic Dermatitis With Abrocitinib: A Phase 3 Extension Study (JADE EXTEND)

Kristian Reich, Jonathan I. Silverberg, Kim Papp, Mette Deleuran, Norito Katoh, Bruce Strober, Lisa A. Beck, Marjolein de Bruin-Weller, Thomas Werfel, Fan Zhang, Pinaki Biswas, Marco DiBonaventura, Gary L. Chan, Saleem A. Farooqui, Urs Kerkmann, Claire Clibborn

#524 - A Phase 3 Double-Blind, Double-Dummy, Active-Controlled, Study to Evaluate the Efficacy and Safety of Abrocitinib Compared to Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis Receiving Background Topical Therapy (JADE DARE)

Kristian Reich, Fernando Valenzuela, H. Chih-ho Hong , Zakiya P. Rice, Fan Zhang, Marco DiBonaventura, Urs Kerkmann, Tamara A. Bratt, Ricardo Rojo, Claire Clibborn

#525 - Efficacy and Safety of Abrocitinib in Adolescents With Moderate-To-Severe Atopic Dermatitis From the JADE Clinical Trial Program

Lawrence F. Eichenfield, Carsten Flohr, Christine Bangert, Alan D. Irvine, Stephan Weidinger, John Nesnas, Herwig Koppensteiner, Fan Zhang, Ricardo Rojo, Gary Chan

#526 - Patient Perspectives of Atopic Dermatitis: Comparative Social Media and Scientific Literature Analysis

Jonathan I. Silverberg, Steven R. Feldman, Wendy Smith Begolka, Marianna B. Johnson, Chrissy Stanojev, Marco DiBonaventura, Ricardo Rojo Cella, Hernan Valdez, Claire Feeney, Jacob P. Thyssen

#530 - Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis

Gabrielle Schwartzman, BS, Donald Lei, MS, Adnan Ahmed, BS, Rajeev Chavda, MD, Sylvie Gabriel, MD, Jonathan I. Silverberg, MD, PhD, MPH

Page 6 of 7
Results 51 - 60 of 65